Valuation China Resources Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 01:38:20 21/10/2026 pm IST			5-day change	1st Jan Change
4.530 ^HKD	-2.69%		-1.95%	+1.80%

19/10	China Resources Pharma Unit Raises 900 Billion Yuan Via Bonds Issue	MT
01/10	China Resources Pharmaceuticals Needs More Than Distribution Scale to Win

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,303	39,705	32,229	35,810	27,957	28,460	-	-
Change	-	78.03%	-18.83%	11.11%	-21.93%	1.8%	-	-
Enterprise Value (EV) ¹	61,337	73,426	71,468	90,725	90,801	77,695	70,988	58,681
Change	-	19.71%	-2.67%	26.95%	0.08%	-14.43%	-8.63%	-17.34%
P/E	5.92x	9.58x	7.76x	10x	6.12x	5.97x	5.6x	5.34x
PBR	0.44x	0.8x	0.32x	0.34x	0.48x	0.45x	0.41x	0.37x
PEG	-	1x	44.15x	-0.7x	0.2x	0.83x	0.84x	1.08x
Capitalization / Revenue	0.09x	0.16x	0.12x	0.13x	0.09x	0.09x	0.08x	0.08x
EV / Revenue	0.26x	0.29x	0.27x	0.33x	0.3x	0.24x	0.21x	0.17x
EV / EBITDA	4.83x	4.38x	4.65x	5.47x	4.73x	3.9x	3.3x	2.82x
EV / EBIT	6.22x	5.39x	5.98x	6.98x	6.23x	4.82x	4.08x	3.35x
EV / FCF	5.88x	7.47x	5.49x	5.73x	4.37x	-28.6x	9.68x	6.5x
FCF Yield	17%	13.4%	18.2%	17.5%	22.9%	-3.5%	10.3%	15.4%
Dividend per Share ²	0.15	0.16	0.1669	0.1445	0.2203	0.2035	0.2202	0.218
Rate of return	4.23%	2.53%	3.25%	2.54%	4.95%	4.37%	4.73%	4.68%
EPS ²	0.6	0.66	0.6612	0.5677	0.7268	0.7794	0.8312	0.8725
Distribution rate	25%	24.2%	25.2%	25.5%	30.3%	26.1%	26.5%	25%
Net sales ¹	2,36,806	2,54,106	2,65,229	2,75,999	3,06,131	3,27,819	3,40,757	3,52,428
EBITDA ¹	12,690	16,775	15,382	16,601	19,202	19,905	21,499	20,777
EBIT ¹	9,868	13,623	11,952	13,005	14,567	16,129	17,398	17,536
Net income ¹	3,769	4,147	4,178	3,589	4,594	4,824	5,178	5,377
Net Debt ¹	39,035	33,720	39,238	54,915	62,844	49,235	42,528	30,221
Reference price ²	3.550	6.320	5.130	5.700	4.450	4.655	4.655	4.655
Nbr of stocks (in thousands)	62,82,510	62,82,510	62,82,510	62,82,510	62,82,510	62,82,510	-	-
Announcement Date	29/03/22	30/03/23	26/03/24	26/03/25	24/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED	5.97x	0.24x	3.94x	4.37%	372.62Cr
ELI LILLY AND COMPANY	36.99x	13.22x	28x	0.53%	1,14400Cr
JOHNSON & JOHNSON	37.96x	6.39x	17.99x	2.06%	63TCr
ABBVIE INC.	36.9x	8.47x	17.49x	2.38%	51TCr
ROCHE HOLDING AG	21.13x	5.1x	12.68x	2.57%	38TCr
MERCK & CO., INC.	108.1x	6.04x	25.89x	2.3%	37TCr
NOVARTIS AG	21.5x	5.61x	13.79x	2.85%	29TCr
ASTRAZENECA PLC	22.06x	4.46x	12.76x	1.98%	26TCr
AMGEN INC.	27.87x	7.15x	12.8x	2.3%	24TCr
GILEAD SCIENCES, INC.	-45.73x	7.01x	27.13x	2.11%	19TCr
Average	27.28x	6.37x	17.25x	2.34%	40.12TCr
Weighted average by Cap.	35.46x	8.34x	20.48x	1.8%